全文获取类型
收费全文 | 4778篇 |
免费 | 295篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 244篇 |
妇产科学 | 80篇 |
基础医学 | 559篇 |
口腔科学 | 149篇 |
临床医学 | 680篇 |
内科学 | 1307篇 |
皮肤病学 | 111篇 |
神经病学 | 199篇 |
特种医学 | 484篇 |
外国民族医学 | 2篇 |
外科学 | 396篇 |
综合类 | 83篇 |
一般理论 | 5篇 |
预防医学 | 339篇 |
眼科学 | 42篇 |
药学 | 177篇 |
2篇 | |
肿瘤学 | 253篇 |
出版年
2021年 | 42篇 |
2020年 | 33篇 |
2019年 | 50篇 |
2018年 | 80篇 |
2017年 | 53篇 |
2016年 | 59篇 |
2015年 | 75篇 |
2014年 | 98篇 |
2013年 | 125篇 |
2012年 | 136篇 |
2011年 | 171篇 |
2010年 | 172篇 |
2009年 | 167篇 |
2008年 | 183篇 |
2007年 | 246篇 |
2006年 | 186篇 |
2005年 | 181篇 |
2004年 | 148篇 |
2003年 | 124篇 |
2002年 | 138篇 |
2001年 | 104篇 |
2000年 | 101篇 |
1999年 | 95篇 |
1998年 | 163篇 |
1997年 | 181篇 |
1996年 | 155篇 |
1995年 | 130篇 |
1994年 | 133篇 |
1993年 | 108篇 |
1992年 | 103篇 |
1991年 | 85篇 |
1990年 | 100篇 |
1989年 | 103篇 |
1988年 | 97篇 |
1987年 | 104篇 |
1986年 | 90篇 |
1985年 | 98篇 |
1984年 | 67篇 |
1983年 | 64篇 |
1982年 | 47篇 |
1981年 | 44篇 |
1980年 | 53篇 |
1979年 | 34篇 |
1978年 | 37篇 |
1977年 | 51篇 |
1976年 | 47篇 |
1975年 | 38篇 |
1974年 | 25篇 |
1972年 | 25篇 |
1971年 | 28篇 |
排序方式: 共有5153条查询结果,搜索用时 0 毫秒
1.
As millions of people turn to social media for health information, better understanding the factors that guide health-related judgments and perceptions in this context is imperative. We report on two Web experiments (n > 400 total) examining the power of society’s widespread weight bias and related stereotypes to influence nutrition judgments in social media spaces. In Experiment 1, meals were judged as lower in nutritional quality when the person who recommended them (the source) was depicted as obese rather than of normal weight, an effect mediated by stereotypic beliefs about the source as a generally unhealthy person. Experiment 2 replicated this effect, which—notably—remained significant when controlling for objective nutritional information (calories and fat content). Results highlight spillover effects of weight bias that extend beyond person perception to color impressions of objects (here, food) that are associated with stigmatized attributes. Implications for everyday nutrition judgments and public health are considered. 相似文献
2.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
3.
4.
Donald B. Penzien PhD ; Frank Andrasik PhD ; Brian M. Freidenberg PhD ; Timothy T. Houle PhD ; Alvin E. Lake III PhD; Gay L. Lipchik PhD ; Kenneth A. Holroyd PhD ; Richard B. Lipton MD ; Douglas C. McCrory MD ; Justin M. Nash PhD ; Robert A. Nicholson PhD ; Scott W. Powers PhD ABPP ; Jeanetta C. Rains PhD ; David A. Wittrock PhD 《Headache》2005,45(S2):S110-S132
Guidelines for design of clinical trials evaluating behavioral headache treatments were developed to facilitate production of quality research evaluating behavioral therapies for management of primary headache disorders. These guidelines were produced by a Workgroup of headache researchers under auspices of the American Headache Society. The guidelines are complementary to and modeled after guidelines for pharmacological trials published by the International Headache Society, but they address methodologic considerations unique to behavioral and other nonpharmacological treatments. Explicit guidelines for evaluating behavioral headache therapies are needed as the optimal methodology for behavioral (and other nonpharmacologic) trials necessarily differs from the preferred methodology for drug trials. In addition, trials comparing and integrating drug and behavioral therapies present methodological challenges not addressed by guidelines for pharmacologic research. These guidelines address patient selection, trial design for behavioral treatments and for comparisons across multiple treatment modalities (eg, behavioral vs pharmacologic), evaluation of results, and research ethics. Although developed specifically for behavioral therapies, the guidelines may apply to the design of clinical trials evaluating many forms of nonpharmacologic therapies for headache. 相似文献
5.
C Gay Escoda 《Avances en Odontoestomatología》1987,3(4):169-72, 175-9
6.
G. Bradley Schaefer James N. Thompson John B. Bodensteiner James M. McConnell William J. Kimberling Charles T. Gay William D. Dutton David C. Hutchings Stanton B. Gray 《Annals of neurology》1996,39(3):382-385
There are conflicting reports on the relationship between cerebellar vermal lobule hypoplasia and autism. Using quantitative magnetic resonance image analysis, we measured the cerebellar vermis in 125 normal individuals with a broad age range and 102 patients with a variety of neurogenetic abnormalities. We conclude that hypoplasia of cerebellar vermal lobules VI and VII is a nonspecific finding that even occurs in several conditions without autistic behavior. This suggests that it is not a specific neuroanatomical marker for autism, nor is cerebellar dys- genesis likely to be solely responsible for clinical autistic behaviors. 相似文献
7.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
8.
9.
10.